age
OtherWe compare the young and the old groups
NCT Number: NCT07405060
Muscle fatigue is one of the clinical symptoms in elderly people and demonstrates task dependency and muscle dependency. Muscle fatigue has been shown to negatively impact postural control, physical activity, and quality of life. However, the evidence for the influence of muscle fatigue on postural control is limited and inconsistent in elderly people. Therefore, this study aims to investigate the impacts of aging and muscle fatigue on postural control and gait performance with fatiguing exercises of upper and lower extremities.
Interested in participating?
Request Info20 year–85 year
All sexes
Observational
Chang Gung Memorial Hospital, Taoyuan, Taiwan
This study aims to investigate the effects of muscle fatigue on postural control and gait performance in healthy older adults (≥65 years) and young adults (20-40 years). Neuromuscular fatigue has been associated with postural instability, but its influence on gait and potential age-related differences remain unclear. Therefore, this study will compare fatigue-induced changes in motor performance between age groups and examine whether fatigue of the upper and lower extremities produces similar functional effects.
Healthy older adults and young adults will be recruited from the community. Eligible participants must be in good health, able to walk independently, demonstrate normal cognitive function, and provide informed consent. Individuals with neurological, cardiovascular, musculoskeletal, or other conditions that may affect motor performance will be excluded.
A repeated-measures design will be used. The study will involve two laboratory sessions separated by at least one week. Participants will undergo pre-test assessments, a fatiguing exercise protocol, and post-test assessments. Motor outcomes-including maximal voluntary isometric contraction, postural control, and gait performance-will be measured before and after the fatiguing exercises. Fatiguing exercises will consist of repeated cycles of maximal contractions with rest periods, while heart rate and perceived exertion are monitored to ensure safety. The protocol will terminate if exertion reaches a predefined threshold or heart rate exceeds the age-predicted maximum.
Surface electromyography and electrical stimulation will be used to assess neuromuscular function. Postural control will be evaluated using a force plate under multiple standing conditions, and gait parameters will be measured while participants walk at comfortable and fast speeds. Statistical analyses will use repeated-measures mixed-model ANOVAs to examine the effects of age group and fatigue on motor outcomes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We compare the young and the old groups
We compare the results before and after muscle fatigue
Time frame: Baseline (pre-fatigue protocol) and immediately after the fatigue protocol
The maximal force of upper and lower extremity muscles
Time frame: Baseline (pre-fatigue protocol) and immediately after the fatigue protocol
The time taken by participants to walk a standardized distance
Time frame: Baseline (pre-fatigue protocol) and immediately after the fatigue protocol
The linear distance between the two ankles, typically expressed in centimeter(cm).
Time frame: Baseline (pre-fatigue protocol) and immediately after the fatigue protocol
The number of steps taken per minute (SPM)
Time frame: Baseline (pre-fatigue protocol) and immediately after the fatigue protocol
The duration within the gait cycle when only one foot is in contact with the ground, typically measured in seconds or as a percentage of the total gait cycle.
Time frame: Baseline (pre-fatigue protocol) and immediately after the fatigue protocol
The portion of the gait cycle where both feet are in contact with the ground, indicating the transition phase between steps, expressed as a percentage of the gait cycle or in seconds.
Time frame: Baseline (pre-fatigue protocol) and immediately after the fatigue protocol
The portion of the gait cycle where the foot is not in contact with the ground, moving forward to the next step. It is usually expressed as a percentage of the total gait cycle or in seconds.
Time frame: Baseline (pre-fatigue protocol) and immediately after the fatigue protocol
The speed at which the COP moves, calculated over the duration of the balance task. Higher velocities may reflect more dynamic balance adjustments or instability. Unit:millimeter per second(mm/s)
Time frame: Baseline (pre-fatigue protocol) and immediately after the fatigue protocol
The area covered by the COP trajectory during the balance task, providing an estimate of the sway envelope. A larger area might indicate poorer balance control. Unit:square millimeter(mm^2)
Time frame: Baseline (pre-fatigue protocol), during the fatigue protocol, and immediately after the fatigue protocol.
Oxygenated hemoglobin is the amount of hemoglobin bound to oxygen, reflecting tissue oxygen availability. It's expressed as the percentage.
Time frame: Baseline (pre-fatigue protocol), during the fatigue protocol, and immediately after the fatigue protocol.
Total hemoglobin is the combined amount of oxygenated and deoxygenated hemoglobin, reflecting overall blood volume in the tissue.
Time frame: Baseline (pre-fatigue protocol), during the fatigue protocol, and immediately after the fatigue protocol.
Deoxygenated hemoglobin is the amount of hemoglobin not bound to oxygen, reflecting oxygen extraction by tissues. It's expressed as the percentage.
Contact information is provided by the study sponsor or research team.
Chang Gung Memorial Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07414680
Aging, Behavior
Taipei, Taiwan
View Trial DetailsNCT07099053
Aging, Alzheimer Disease
Baltimore, Maryland, United States
View Trial DetailsNCT06269939
Aging
East Hanover, New Jersey, United States
View Trial DetailsNCT07461584
Aging, Memory
Boston, Massachusetts, United States
View Trial Details